Dynavax Technologies reported $73.98M in Stock for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Adma Biologics ADMA:US $ 146.07M 6.93M
Amgen AMGN:US $ 4554M 143M
Biogen BIIB:US $ 1294.2M 78.8M
Biomarin Pharmaceutical BMRN:US $ 802.32M 15.96M
Bristol Myers Squibb BMY:US $ 2142M 38M
Chimerix CMRX:US 4.13M 720K
Dynavax Technologies DVAX:US $ 73.98M 5.06M
Gilead Sciences GILD:US $ 2587M 88M
Nektar Therapeutics NKTR:US $ 16.97M 1.59M
Neurocrine Biosciences NBIX:US $ 29.3M 0.3M
Novartis NOVN:VX SF 6880M 117M
Regeneron Pharmaceuticals REGN:US $ 2218.5M 227M
Sarepta Therapeutics SRPT:US $ 208.1M 9.1M
Vertex Pharmaceuticals VRTX:US $ 367.7M 28.8M